950 related articles for article (PubMed ID: 32376411)
1. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
2. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
[TBL] [Abstract][Full Text] [Related]
3. A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma.
Nishiwada S; Sho M; Cui Y; Yamamura K; Akahori T; Nakagawa K; Nagai M; Nakamura K; Takagi T; Ikeda N; Li W; Baba H; Goel A
Int J Cancer; 2021 Feb; 148(3):769-779. PubMed ID: 32895958
[TBL] [Abstract][Full Text] [Related]
4. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
Kandimalla R; Shimura T; Mallik S; Sonohara F; Tsai S; Evans DB; Kim SC; Baba H; Kodera Y; Von Hoff D; Chen X; Goel A
Ann Surg; 2022 Jan; 275(1):e229-e237. PubMed ID: 32398486
[TBL] [Abstract][Full Text] [Related]
5. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.
Brand RE; Adai AT; Centeno BA; Lee LS; Rateb G; Vignesh S; Menard C; Wiechowska-Kozłowska A; Bołdys H; Hartleb M; Sanders MK; Munding JB; Tannapfel A; Hahn SA; Stefańczyk L; Tsongalis GJ; Whitcomb DC; Conwell DL; Morisset JA; Gardner TB; Gordon SR; Suriawinata AA; Lloyd MB; Wylie D; Labourier E; Andruss BF; Szafranska-Schwarzbach AE
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1717-23. PubMed ID: 24662333
[TBL] [Abstract][Full Text] [Related]
6. Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies.
Frampton AE; Krell J; Prado MM; Gall TM; Abbassi-Ghadi N; Del Vecchio Blanco G; Funel N; Giovannetti E; Castellano L; Basyouny M; Habib NA; Kaltsidis H; Vlavianos P; Stebbing J; Jiao LR
Oncotarget; 2016 May; 7(19):28556-69. PubMed ID: 27086919
[TBL] [Abstract][Full Text] [Related]
7. Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma.
Suzuki R; Irie H; Takagi T; Sugimoto M; Konno N; Sato Y; Watanabe K; Nakamura J; Marubashi S; Hikichi T; Ohira H
BMC Cancer; 2018 Oct; 18(1):974. PubMed ID: 30314433
[TBL] [Abstract][Full Text] [Related]
8. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
[TBL] [Abstract][Full Text] [Related]
9. Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.
Park JK; Lee JH; Noh DH; Park JK; Lee KT; Lee JK; Lee KH; Jang KT; Cho J
Gut Liver; 2020 May; 14(3):387-394. PubMed ID: 31581388
[TBL] [Abstract][Full Text] [Related]
10. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
[TBL] [Abstract][Full Text] [Related]
11. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
Wada Y; Shimada M; Murano T; Takamaru H; Morine Y; Ikemoto T; Saito Y; Balaguer F; Bujanda L; Pellise M; Kato K; Saito Y; Ikematsu H; Goel A
Gastroenterology; 2021 Jul; 161(1):151-162.e1. PubMed ID: 33819484
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma.
Nishiwada S; Cui Y; Sho M; Jun E; Akahori T; Nakamura K; Sonohara F; Yamada S; Fujii T; Han IW; Tsai S; Kodera Y; Park JO; Von Hoff D; Kim SC; Li W; Goel A
Ann Surg; 2022 Dec; 276(6):e876-e885. PubMed ID: 34132691
[TBL] [Abstract][Full Text] [Related]
13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.
Jamieson NB; Morran DC; Morton JP; Ali A; Dickson EJ; Carter CR; Sansom OJ; Evans TR; McKay CJ; Oien KA
Clin Cancer Res; 2012 Jan; 18(2):534-45. PubMed ID: 22114136
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
[TBL] [Abstract][Full Text] [Related]
16. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
17. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
Nakamura K; Zhu Z; Roy S; Jun E; Han H; Munoz RM; Nishiwada S; Sharma G; Cridebring D; Zenhausern F; Kim S; Roe DJ; Darabi S; Han IW; Evans DB; Yamada S; Demeure MJ; Becerra C; Celinski SA; Borazanci E; Tsai S; Kodera Y; Park JO; Bolton JS; Wang X; Kim SC; Von Hoff D; Goel A
Gastroenterology; 2022 Nov; 163(5):1252-1266.e2. PubMed ID: 35850192
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma.
Preis M; Gardner TB; Gordon SR; Pipas JM; Mackenzie TA; Klein EE; Longnecker DS; Gutmann EJ; Sempere LF; Korc M
Clin Cancer Res; 2011 Sep; 17(17):5812-21. PubMed ID: 21652542
[TBL] [Abstract][Full Text] [Related]
20. Snail transcript levels in diagnosis of pancreatic carcinoma with fine-needle aspirate.
Wang Z; Zhao L; Xiao Y; Gao Y; Zhao C
Br J Biomed Sci; 2015; 72(3):107-10. PubMed ID: 26510265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]